165 related articles for article (PubMed ID: 15792256)
21. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance in a rural Maori community.
Tipene-Leach D; Pahau H; Joseph N; Coppell K; McAuley K; Booker C; Williams S; Mann J
N Z Med J; 2004 Dec; 117(1207):U1208. PubMed ID: 15608803
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes.
Ioannou GN; Bryson CL; Boyko EJ
J Diabetes Complications; 2007; 21(6):363-70. PubMed ID: 17967708
[TBL] [Abstract][Full Text] [Related]
24. Glucose metabolism in the idiopathic blepharoptosis: utility of the Oral Glucose Tolerance Test (OGTT) and of the Insulin Resistance Index.
Bosco D; Costa R; Plastino M; Branca D; Cotronei P; Sperlì T; Santacroce N; Siniscalchi A; Consoli D; Ceccotti C; Mungari P; Fava A
J Neurol Sci; 2009 Sep; 284(1-2):24-8. PubMed ID: 19361813
[TBL] [Abstract][Full Text] [Related]
25. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
Gokulakrishnan K; Deepa R; Mohan V; Gross MD
Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
[TBL] [Abstract][Full Text] [Related]
26. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome and prediabetes identify overlapping but not identical populations.
Diamantopoulos EJ; Andreadis EA; Tsourous GI; Ifanti GK; Katsanou PM; Georgiopoulos DX; Vassilopoulos CV; Dimitriadis G; Raptis SA
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):377-83. PubMed ID: 16915541
[TBL] [Abstract][Full Text] [Related]
28. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population.
Hadaegh F; Ghasemi A; Padyab M; Tohidi M; Azizi F
Diabetes Res Clin Pract; 2008 May; 80(2):328-34. PubMed ID: 18282630
[TBL] [Abstract][Full Text] [Related]
29. Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp.
Piché ME; Lemieux S; Corneau L; Nadeau A; Bergeron J; Weisnagel SJ
Metabolism; 2007 Sep; 56(9):1159-66. PubMed ID: 17697856
[TBL] [Abstract][Full Text] [Related]
30. Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study.
Golley RK; Magarey AM; Steinbeck KS; Baur LA; Daniels LA
Int J Obes (Lond); 2006 May; 30(5):853-60. PubMed ID: 16404409
[TBL] [Abstract][Full Text] [Related]
31. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study.
Cameron AJ; Magliano DJ; Zimmet PZ; Welborn TA; Colagiuri S; Tonkin AM; Shaw JE
J Intern Med; 2008 Aug; 264(2):177-86. PubMed ID: 18298479
[TBL] [Abstract][Full Text] [Related]
32. Impaired glucose tolerance and impaired fasting glucose.
Rao SS; Disraeli P; McGregor T
Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
[TBL] [Abstract][Full Text] [Related]
34. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
[TBL] [Abstract][Full Text] [Related]
35. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.
Hoffman-Snyder C; Smith BE; Ross MA; Hernandez J; Bosch EP
Arch Neurol; 2006 Aug; 63(8):1075-9. PubMed ID: 16769858
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome as a risk factor for diabetes.
Aschner P
Expert Rev Cardiovasc Ther; 2010 Mar; 8(3):407-12. PubMed ID: 20222818
[TBL] [Abstract][Full Text] [Related]
38. Screening for metabolic syndrome in hypertensive and/or obese subjects registered in primary health care in Hungary.
Hidvégi T; Hetyési K; Bíró L; Jermendy G
Med Sci Monit; 2003 Jul; 9(7):CR328-34. PubMed ID: 12883453
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of metabolic syndrome in obese Turkish children and adolescents.
Atabek ME; Pirgon O; Kurtoglu S
Diabetes Res Clin Pract; 2006 Jun; 72(3):315-21. PubMed ID: 16325296
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
